HR-9598 : Still Just a Bill

The "Office of National Drug Control Policy Reauthorization Act of 2024" (H.R. 9598) amends the Office of National Drug Control Policy Reauthorization Act of 1998 to reauthorize the Office of National Drug Control Policy (ONDCP). Key provisions include:

• Reauthorization: Extends the authorization of the ONDCP through 2031.
• Emerging Drug Threats: Updates the definition of "emerging drug threat" to include new methods of drug consumption and trafficking.
• Precursor Chemicals: Defines "precursor chemical" to include listed and unregulated chemicals used in illicit drug production.
• National Drug Control Strategy: Requires coordination with the Department of Homeland Security, the Attorney General, and the Secretary of State to ensure adequate resources for drug control and illicit drug trafficking enforcement.
• High Intensity Drug Trafficking Areas (HIDTA): Enhances fentanyl seizure and interdiction activities through HIDTA grants.
• Data Collection and Analysis: Requires the ONDCP to collect and analyze data on drug use, overdoses, and treatment effectiveness, and to make this data publicly available.
• Caribbean Border Counternarcotics Strategy: Mandates a strategy to prevent drug trafficking through the Caribbean region, including Puerto Rico and the U.S. Virgin Islands.
• Opioid Overdose Reversal: Requires a report on ensuring access to life-saving opioid overdose reversal medications, such as naloxone.
• Pill Press Machines: Directs the ONDCP to publish a report with ways to regulate the shipment of pill press machines and their critical parts.
• Community Anti-Drug Coalitions: Reauthorizes funding for the National Community Anti-Drug Coalition Institute and community-based coalition enhancement grants.
• Data Analytical Services Program: Requires a biennial report on activities of the Data Analytical Services program.